Form 4: ANI Pharma Executive Sells Shares Under 10b5-1 Plan

ANI Pharmaceuticals' SR. VP, General Counsel & Secretary, Meredith Cook, sold 400 shares of common stock for $82.32 per share under a Rule 10b5-1 trading plan.

Summary

• Meredith Cook, SR. VP, General Counsel & Secretary of ANI Pharmaceuticals Inc. (ANIP), reported a sale of common stock.
• The transaction involved the disposition of 400 shares of common stock.
• The shares were sold at a price of $82.32 per share.
• The sale was executed on December 12, 2025.
• This transaction was made pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on September 17, 2024.
• Following this transaction, Meredith Cook beneficially owns 74,874 shares of ANI Pharmaceuticals common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider sale executed under a pre-established Rule 10b5-1 trading plan, which is generally considered a neutral event and does not indicate a change in company fundamentals or outlook.

Industry Context

This is a routine insider transaction and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual executive's pre-planned stock disposition.

Stakeholder Impact

• Shareholders: A minor, pre-planned sale by an executive is unlikely to have a significant impact on shareholder sentiment or the company's stock price.

Key Dates

Recommendation

The reported transaction is a routine insider sale executed under a pre-established Rule 10b5-1 trading plan, indicating it was not based on new material non-public information. Such a transaction typically does not warrant a change in investment recommendation for the stock, maintaining a 'hold' stance unless other fundamental factors suggest otherwise.

Keywords

ANI Pharmaceuticals, ANIP, Insider Sale, Form 4, Meredith Cook, Rule 10b5-1, Common Stock